Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma (PREVAIL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03788746
Recruitment Status : Active, not recruiting
First Posted : December 28, 2018
Last Update Posted : May 24, 2022
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 5, 2021
Estimated Study Completion Date : June 7, 2023